Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This testing period covers the most vulnerable phase of embryonic development when cancer-causing substances would be most likely to produce abnormalities
It does not require encapsulation, a carrier molecule, or special formulation to maintain structural integrity in biological environments
[PMID: 2390054] PubMed record related to this compound for laboratory literature review
Additional information Reviews There are no reviews yet
Chemical Makeup Molecular Formula: C 212 H 350 N 56 O 78 S Molecular Weight: 4963 g/mol Other Known Titles: Thymosin Beta 4 Research and Clinical Studies TB-500 Peptide and Inflammation T4, and thus TB-500, is thought to potentially increase the levels of microRNA-146a (miR-146a), which might function as a suppressive regulator of specific cellular signaling pathways, particularly those associated with the functions of inflammation-related cytokines, including L-1 receptor-linked kinase 1 (IRAK1) and tumor necrosis factor receptor-associated factor 6 (TRAF6)
It inhibits NNMT (nicotinamide N-methyltransferase), an enzyme regulating metabolism, fat storage, and NAD+ consumption.[4][27][6] NNMT methylates nicotinamide, a NAD+ breakdown product, diverting it from recycling and reducing available NAD+
